DIABETES MELITUS TIPE 2: FAKTOR RISIKO, DIAGNOSIS, DAN TATALAKSANA
DOI:
https://doi.org/10.23887/gm.v1i2.40006Keywords:
Diabetes mellitus, risk factors, diagnosis, managementAbstract
Abstrak
Diabetes melitus menggambarkan sekelompok penyakit metabolik yang temuan umumnya adalah kadar glukosa darah yang meningkat. Pada usia 20-79 tahun, terdapat 463 juta atau setara 9,3% orang di dunia menderita diabetes pada tahun 2019. Diabetes melitus tipe 2 ditandai dengan defisiensi insulin relatif yang disebabkan oleh disfungsi sel pankreas dan resistensi insulin. Faktor risiko penyebabnya dibagi menjadi dua yaitu faktor risiko yang dapat dimodifikasi dan tidak dapat dimodifikasi. Gejala klasik diabetes seperti poliuria, polidipsia, polifagia dan penurunan berat badan yang tidak dapat dijelaskan sebabnya. Empat tes diagnostik untuk diabetes yaitu pengukuran glukosa plasma puasa, glukosa plasma 2 jam setelah TTGO 75 g, HbA1c, dan glukosa darah acak dengan adanya tanda dan gejala klasik diabetes. Tatalaksana dibagi menjadi dua, yaitu farmakologi dan non farmakologi. Tatalaksana non farmakologis terdiri atas edukasi, nutrisi medis, dan latihan fisik. Terapi farmakologis terdiri atas obat oral dan bentuk suntikan dalam bentu obat anti hiperglikemik dan insulin. Terapi farmakologi dan non farmakologi ini berjalan beriringan. Penulisan artikel ini menggunakan metode literature review dan diharapkan dapat dijadikan acuan kedepan dalam melakukan tindakan pencegahan dan pengobatan pasien diabetes melitus sehingga prevalensi berkurang dan komplikasi dapat dihindari.
Abstract
Diabetes mellitus describes a group of metabolic diseases whose common finding is elevated blood glucose levels. At the age of 20-79 years, there were 463 million or 9.3% of people in the world suffer from diabetes in 2019. Type 2 diabetes mellitus is characterized by relative insulin deficiency caused by pancreatic cell dysfunction and insulin resistance. The risk factors that cause it are divided into two, namely modifiable and non-modifiable risk factors. The classic symptoms of diabetes include polyuria, polydipsia, polyphagia and unexplained weight loss. The four diagnostic tests for diabetes are measurement of fasting plasma glucose, plasma glucose 2 hours after OGTT 75 g, HbA1c, and randomized blood glucose in the presence of classic signs and symptoms of diabetes. Treatment is divided into two, namely pharmacological and non-pharmacological. Non-pharmacological management consists of education, medical nutrition, and physical exercise. Pharmacological therapy consists of oral drugs and injections in the form of anti-hyperglycemic drugs and insulin. Pharmacological and non-pharmacological therapy goes hand in hand. The writing of this article uses the literature review method and is expected to be used as a future reference in carrying out prevention and treatment of diabetes mellitus patients so that prevalence is reduced and complications can be avoided.
References
WHO. Noncommunicable diseases [Internet]. 2018 [cited 2021 Apr 4]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol [Internet]. 2018;14(2):88–98. Available from: http://dx.doi.org/10.1038/nrendo.2017.151
Kementrian Kesehatan RI. Infodatin: Tetap Produktif, Cegah, dan Atasi Diabetes Melitus. 2020.
Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Buku Pedoman Penyakit Tidak Menular. Kementeri Kesehat RI [Internet]. 2019;101. Available from: http://p2ptm.kemkes.go.id/uploads/VHcrbkVobjRzUDN3UCs4eUJ0dVBndz09/2019/03/Buku_Pedoman_Manajemen_PTM.pdf
Harreiter J, Roden M. Diabetes mellitus—Definition, classification, diagnosis, screening and prevention (Update 2019). Wien Klin Wochenschr. 2019;131(Update):6–15.
Ismail L, Materwala H, Kaabi J Al. Association of Risk Factors with Type 2 Diabetes : A Systematic Review. Comput Struct Biotechnol J [Internet]. 2021; Available from: https://doi.org/10.1016/j.csbj.2021.03.003
Carbone S, Del Buono MG, Ozemek C, Lavie CJ. Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness. Prog Cardiovasc Dis [Internet]. 2019;62(4):327–33. Available from: https://doi.org/10.1016/j.pcad.2019.08.004
Rice Bradley BH. Dietary Fat and Risk for Type 2 Diabetes: a Review of Recent Research. Curr Nutr Rep. 2018;7(4):214–26.
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316.
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet [Internet]. 2017;389(10085):2239–51. Available from: http://dx.doi.org/10.1016/S0140-6736(17)30058-2
Parkeni. Konsesus Pengelolaan Dan Pencegahan Diabetes Melitus Tipe2 Di Indonesia 2015 [Internet]. Perkeni. 2015. 82 p. Available from: https://www.google.com/url?sa=t&source=web&rct=j&url=https://pbperkeni.or.id/wp-content/uploads/2019/01/4.-Konsensus-Pengelolaan-dan-Pencegahan-Diabetes-melitus-tipe-2-di-Indonesia-PERKENI-2015.pdf&ved=2ahUKEwjy8KOs8cfoAhXCb30KHQb1Ck0QFjADegQIBhAB&usg=AOv
Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein HH, et al. Therapy of type 2 diabetes. Exp Clin Endocrinol Diabetes. 2019;127(1):S73–92.
Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–200.
Setyorogo S, Trisnawati S. Faktor Resiko Kejadian Diabetes Melitus Tipe II Di Puskesmas Kecamatan Cengkareng Jakarta Barat Tahun 2012. J Ilm Kesehat. 2013;5(1):6–11.
Isnaini N, Ratnasari R. Faktor risiko mempengaruhi kejadian Diabetes mellitus tipe dua. J Kebidanan dan Keperawatan Aisyiyah. 2018;14(1):59–68.
Utomo AA, Aulia A, Rahmah S, Amalia R. Faktor Risiko Diabetes Mellitus Tipe 2: A Systematic Review. J Kaji dan Pengemb Kesehat Masy [Internet]. 2020;1(1):44–52. Available from: https://jurnal.umj.ac.id/index.php/AN-NUR
WHO. Classification of diabetes mellitus. Vol. 21, Clinics in Laboratory Medicine. 2019.
Cannata F, Vadalà G, Russo F, Papalia R, Napoli N, Pozzilli P. Beneficial effects of physical activity in diabetic patients. J Funct Morphol Kinesiol. 2020;5(3).
Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586–93.
